Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Biologics Testing Market: By Product Type, By Test, By Application, By Region Forecast 2020-2031
Biologics Testing Market: By Product Type, By Test, By Application, By Region Forecast 2020-2031
Biologics Testing Market size was valued at US$ 3.2 billion in 2023, growing at a significant CAGR of 11.8% from 2024-2030. The market report provides an in-depth analysis of the impact of COVID-19 on the market, along with revised market size due to the effects of the coronavirus. The increase in R&D investment in the biopharma industry coupled with the increase in new product launches are expected to bolster the market growth over the forecast period. Biologics are complex compounds made from the genes of live creatures and combined utilizing modern DNA technologies. Biologics are cutting-edge medications that are used to treat cancer, cardiovascular disease, rheumatoid arthritis, and other illnesses.
Large molecules such as monoclonal antibodies and recombinant proteins are classified as biologics, and their safety ensures patient safety because they are utilized to treat the diseases listed above. Recombinant proteins, tissues, genes, allergens, cells, blood components, and vaccinations are all examples of biological medications made from live creatures. Biologics are items that are made from living organisms and have specific properties. For new product categories, biological safety assessment is critical. Biological safety testing is done to guarantee that vaccines and biopharmaceuticals are not contaminated and that they meet safety quality standards. Kits and reagents, as well as instruments, make up the product segment.
Study Period
2025-2031Base Year
2024CAGR
11.8%Largest Market
North-AmericaFastest Growing Market
Europe
The biologics testing market is mainly driven by the strengthening of the regulatory procedures in many countries for the approval and marketing of the biological products. In addition, robust growth in biopharmaceutical industry and increase in prevalence of the diseases among the population expected to boost the market share.
Geographically, the biologics testing market is segmented into North America, Europe, Middle East and Africa, Asia Pacific and Latin America. North America market expected to have the significant share and growth rate owing to the factors such as presence of major biological companies, increase in R&D related to the biologicals coupled with the favorable regulatory environment for the biological test service providers. Europe market projected to grow at notable rates owing to the high growth rate of biopharmaceutical industryand growing prevalence of the various diseases intern stimulating the development of new biopharmaceuticals. Asia Pacific region projected to have lucrative growth opportunity over the forecast period owing to the low cost of production and labor, development of healthcare infrastructure and increase in medical spending by the population.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2023 |
US$ 3.2 billion |
|
Market CAGR |
11.8% |
|
By Product Type |
|
|
By Application |
|
|
By Test |
|
|
By Region |
|
Download Free Sample Report
The global biologics testing market size was valued at US$ 3.2 billion in 2023, growing at a significant CAGR of 11.8% from 2024-2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1. Executive Summary |
| 2. Global Biologics Testing Market Introduction |
| 2.1.Global Biologics Testing Market - Taxonomy |
| 2.2.Global Biologics Testing Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.Test |
| 2.2.4.Region |
| 3. Global Biologics Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Biologics Testing Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Biologics Testing Market By Product Type , 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Instruments |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Kits and Reagents |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Services |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Biologics Testing Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Cellular and Gene related |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Blood and Blood Products |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Vaccines |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Stem cell Research |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Biologics Testing Market By Test, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Sterility Test |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Endotoxin Test |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Cell Line Authentication and Characterization |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Residual Host Contamination Test |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global Biologics Testing Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Biologics Testing Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Instruments |
| 9.1.2.Kits and Reagents |
| 9.1.3.Services |
| 9.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Cellular and Gene related |
| 9.2.2.Blood and Blood Products |
| 9.2.3.Vaccines |
| 9.2.4.Stem cell Research |
| 9.2.5.Others |
| 9.3. Test Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Sterility Test |
| 9.3.2.Endotoxin Test |
| 9.3.3.Cell Line Authentication and Characterization |
| 9.3.4.Residual Host Contamination Test |
| 9.3.5.Others |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Biologics Testing Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Instruments |
| 10.1.2.Kits and Reagents |
| 10.1.3.Services |
| 10.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Cellular and Gene related |
| 10.2.2.Blood and Blood Products |
| 10.2.3.Vaccines |
| 10.2.4.Stem cell Research |
| 10.2.5.Others |
| 10.3. Test Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Sterility Test |
| 10.3.2.Endotoxin Test |
| 10.3.3.Cell Line Authentication and Characterization |
| 10.3.4.Residual Host Contamination Test |
| 10.3.5.Others |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Biologics Testing Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Instruments |
| 11.1.2.Kits and Reagents |
| 11.1.3.Services |
| 11.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Cellular and Gene related |
| 11.2.2.Blood and Blood Products |
| 11.2.3.Vaccines |
| 11.2.4.Stem cell Research |
| 11.2.5.Others |
| 11.3. Test Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Sterility Test |
| 11.3.2.Endotoxin Test |
| 11.3.3.Cell Line Authentication and Characterization |
| 11.3.4.Residual Host Contamination Test |
| 11.3.5.Others |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Biologics Testing Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Instruments |
| 12.1.2.Kits and Reagents |
| 12.1.3.Services |
| 12.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Cellular and Gene related |
| 12.2.2.Blood and Blood Products |
| 12.2.3.Vaccines |
| 12.2.4.Stem cell Research |
| 12.2.5.Others |
| 12.3. Test Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Sterility Test |
| 12.3.2.Endotoxin Test |
| 12.3.3.Cell Line Authentication and Characterization |
| 12.3.4.Residual Host Contamination Test |
| 12.3.5.Others |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Biologics Testing Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Instruments |
| 13.1.2.Kits and Reagents |
| 13.1.3.Services |
| 13.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Cellular and Gene related |
| 13.2.2.Blood and Blood Products |
| 13.2.3.Vaccines |
| 13.2.4.Stem cell Research |
| 13.2.5.Others |
| 13.3. Test Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Sterility Test |
| 13.3.2.Endotoxin Test |
| 13.3.3.Cell Line Authentication and Characterization |
| 13.3.4.Residual Host Contamination Test |
| 13.3.5.Others |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Eurofins Scientific (Luxembourg) |
| 14.2.2.Charles River Laboratories, Inc. (U.S.) |
| 14.2.3.SGS S.A. (Switzerland) |
| 14.2.4.Sartorius AG (Germany) |
| 14.2.5.Cytovance Biologics, Inc. (U.S.) |
| 14.2.6.Pace Analytical Services, LLC. (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.